Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group

J Infect Dis. 1998 Mar;177(3):770-3. doi: 10.1086/514249.

Abstract

Cytomegalovirus (CMV) retinitis is among the most common opportunistic infections in patients with AIDS and a substantial cause of visual loss. With long-term therapy, resistant CMV may develop. In a prospective study of 108 patients with CMV retinitis, 80.6% of patients were found to have either a positive blood culture or positive urine culture for CMV at the diagnosis of retinitis. At diagnosis of retinitis, 0.9% and 2.7% of patients had a ganciclovir-resistant blood culture isolate and urine culture isolate, respectively. Of 76 patients initially treated with ganciclovir, 11.4% had a resistant blood or urine culture isolate by 6 months of treatment and 27.5% by 9 months. The development of ganciclovir resistance during follow-up correlated with the occurrence of CMV retinitis in the contralateral eye (odds ratio = 9.06, P = .003).

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • Adult
  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus / drug effects*
  • Cytomegalovirus Retinitis / drug therapy*
  • Drug Resistance, Microbial
  • Female
  • Ganciclovir / therapeutic use*
  • Humans
  • Male
  • Proportional Hazards Models
  • Prospective Studies

Substances

  • Antiviral Agents
  • Ganciclovir